Mechanistic target of Rapamycin (mTOR) is a serine-threonine kinase that coordinates nutrient and growth factor availability with cellular growth, division, and differentiation. Studies examining the roles of mTOR signaling in immune function have revealed critical roles for mTOR in regulating T-cell differentiation and function. However, there have been few studies investigating the roles of mTOR in early B cell development. In this study, we found that mTOR is highly activated during the pro- and pre-B stages of mouse B cell development. Conditional disruption of the mTOR co-activating protein Raptor in developing mouse B-cells resulted in a developmental block at the pre-B cell stage, with a corresponding lack of peripheral B-cells and loss of antigen-specific antibody production. Pre-B cell survival and proliferation were significantly reduced in Raptor-deficient mice. Forced expression of a transgenic B cell receptor or a BclxL transgene on Raptor-deficient B cells failed to rescue B cell development suggesting that pre-B cell receptor signaling and B cell survival are impaired in a BclxL-independent manner. Raptor deficient pre-B cells exhibited significant decreases in both oxidative phosphorylation and glycolysis, indicating that loss of mTOR signaling in B cells significantly impairs cellular metabolic capacity. Treatment of mice with Rapamycin, an allosteric inhibitor of mTOR, recapitulated the early B cell developmental block. Collectively, our data reveal a previously uncharacterized role of mTOR signaling in early B cell development, survival, and metabolism.